+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Regenerative Medicine Market By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Others), By Application, By Material, By Cell, By Product, By Technique, By Distribution Channel, By Region, Forecast & Opportunities, 2025

  • ID: 5022578
  • Report
  • May 2020
  • Region: Global
  • 117 pages
  • TechSci Research
The Global Regenerative Medicine Market is Expected to Register a Double Digit CAGR Through 2025.

FEATURED COMPANIES

  • Allergan
  • Bristol-Myers Squibb
  • Corline Biomedical
  • Medtronic
  • Organogenesis
  • Roche
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Regenerative Medicine Market is expected to register a double digit CAGR through 2025 owing to their increasing use in repair, replacement or regeneration of cells, tissues and organs. Additionally, high prevalence of chronic & genetic dieses, emergence of stem cell technology and growing aging populations are some of the key factors driving the regenerative medicine market.

Regenerative medicines deal with process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function. They are also being used to create solutions for organs that become permanently damaged. These medicines are also used in treatment of some uncurable dieses like arthritis and diabetes.

Increasing number of cancer patients, neurodegenerative, orthopedic, and other aging-associated disorders is creating a significant demand for the regenerative medicine market globally. Various countries like United States, China and Japan are investing in stem cell research, which indicates a bright future for regenerative medicine manufacturers.

The Global Regenerative Medicine Market also faces some restraints like high treatment costs, stringent government regulations and operative inefficiency. High investment required for developing the medicine might also limit the market growth.

The market is segmented based on therapy, application, material, cell, product, technique, distribution channel and region. The application segment comprises of musculoskeletal disorders, wound care, oncology, neurology, ocular disorders, diabetes, cardiology and others. Out of them, the musculoskeletal segment is expected to dominate the market during the forecast years owing to growing use of regenerative medicines for treating musculoskeletal disorders and increasing number of orthopedic diseases. Based on material, the regenerative medicine market is segmented into synthetic material, biologically derived material, genetically engineered material and pharmaceutical. The biologically derived material dominated the regenerative medicine market in 2019 and is expected to further hold its position in the coming years due to its unique properties. This type of material promotes cellular interactions, increases proliferation and controls the manipulation of cellular behavior.

Major players operating in the Global Regenerative Medicine Market include Novartis AG, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Roche, Bristol-Myers Squibb, Allergan, Corline Biomedical, Cook Biotech, Pfizer, Baxter, Boehringer Ingelheim, Caladrius Biosciences, Takara Bio, Medtronic, Osiris Therapeutics, Kite Pharma, Organogenesis and others. Due to growing demand from Asia-Pacific region, the manufacturers are focusing on countries like India and China where geriatric population is increasing rapidly.

Years considered for this report:
  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025
Objective of the Study:
  • To analyze and forecast the market size of the Global Regenerative Medicine Market.
  • To classify and forecast the Global Regenerative Medicine Market based on therapy, application, material, cell, product, technique, distribution channel and regional distribution.
  • To identify drivers and challenges for the Global Regenerative Medicine Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Regenerative Medicine Market.
  • To conduct pricing analysis for the Global Regenerative Medicine Market.
  • To identify and analyze the profile of leading players operating in the Global Regenerative Medicine Market.
The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of manufacturers across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the manufacturers which could not be identified due to the limitations of secondary research. The author analyzed the manufacturers, distribution channels and presence of all major players across the globe.

The author calculated the market size of the Global Regenerative Medicine Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. They sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Regenerative medicine manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to regenerative medicines
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Regenerative Medicine Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Therapy:
  • Cell-Based Immunotherapy & Cell Therapy
  • Gene Therapy
  • Tissue-Engineering
  • Immunomodulation Therapy
  • Blood Transfusion
  • Bone Marrow Transplantation
  • Plasma Rich Plasma Therapy
  • Prolotherapy
  • Others
Market, By Application:
  • Musculoskeletal Disorders
  • Wound Care
  • Oncology
  • Neurology
  • Ocular Disorders
  • Diabetes
  • Cardiology
  • Others
Market, By Material:
  • Synthetic Material
  • Biodegradable Synthetic Polymers
  • Scaffold
  • Artificial Vascular Graft Materials
  • Hydrogel Materials
  • Biologically Derived Material
  • Collagen
  • Xenogeneic Material
  • Genetically Engineered Material
  • Genetically Manipulated Cells
  • 3D Polymer Technology
  • Transgenic
  • Fibroblast
  • Neural Stem Cells
  • Gene-activated Matrices
  • Pharmaceutical
  • Small Molecules
  • Biologics
Market, By Cell:
  • Autologous
  • Allogenic
Market, By Product:
  • Biologic
  • Cell -based Medical Devices
  • Biopharmaceutical
  • Biomaterial
Market, By Technique:
  • Microfracture
  • Mosaicplasty
Market, By Distribution Channel:
  • Hospitals
  • Clinics
  • Online
  • Others
Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • South America
  • Brazil
  • Argentina
  • Colombia
Competitive Landscape
  • Company Profiles: Detailed analysis of the major companies present in the Global Regenerative Medicine Market.
Available Customizations:
With the given market data, researchers offers customizations according to a company’s specific needs.

This report will be delivered within 3 business days and will include the latest impact analysis of COVID-19.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan
  • Bristol-Myers Squibb
  • Corline Biomedical
  • Medtronic
  • Organogenesis
  • Roche
1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Regenerative Medicine Market

4. Executive Summary

5. Voice of Customer

6. Global Regenerative Medicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Tissue-Engineering, Immunomodulation therapy, Blood transfusion, Bone marrow transplantation, Plasma rich plasma therapy, Prolotherapy, Others)
6.2.2. By Application (Musculoskeletal Disorders, Wound Care, Oncology, Neurology, Ocular Disorders, Diabetes, Cardiology, Others)
6.2.3. By Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, Pharmaceutical)
6.2.3.1. By Synthetic Material (Biodegradable Synthetic Polymers, Scaffold, Artificial Vascular Graft Materials, Hydrogel Materials)
6.2.3.2. By Biologically Derived Material (Collagen, Xenogeneic Material)
6.2.3.3. By Genetically Engineered Material (Genetically Manipulated Cells, 3D Polymer Technology, Transgenic, Fibroblast, Neural Stem Cells, Gene-activated Matrices)
6.2.3.4. By Pharmaceutical (Small Molecules, Biologics)
6.2.4. By Cell (Autologous, Allogenic)
6.2.5. By Product (Biologic, Cell -based Medical Devices, Biopharmaceutical, Biomaterial)
6.2.6. By Technique (Microfracture, Mosaicplasty)
6.2.7. By Distribution Channel (Hospitals, Clinics, Online, Others)
6.2.8. By Region
6.2.9. By Company

7. North America Regenerative Medicine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Therapy
7.2.2. By Application
7.2.3. By Material
7.2.4. By Cell
7.2.5. By Product
7.2.6. By Technique
7.2.7. By Distribution Channel
7.2.8. By Country (United States; Canada; Mexico and Rest of North America)
7.3. North America: Country Analysis
7.3.1. United States Regenerative Medicine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value & Volume
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapy
7.3.1.2.2. By Application
7.3.1.2.3. By Material
7.3.1.2.4. By Cell
7.3.1.2.5. By Product
7.3.1.2.6. By Technique
7.3.1.2.7. By Distribution Channel
7.3.2. Canada Regenerative Medicine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value & Volume
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapy
7.3.2.2.2. By Application
7.3.2.2.3. By Material
7.3.2.2.4. By Cell
7.3.2.2.5. By Product
7.3.2.2.6. By Technique
7.3.2.2.7. By Distribution Channel
7.3.3. Mexico Regenerative Medicine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value & Volume
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapy
7.3.3.2.2. By Application
7.3.3.2.3. By Material
7.3.3.2.4. By Cell
7.3.3.2.5. By Product
7.3.3.2.6. By Technique
7.3.3.2.7. By Distribution Channel

8. Europe Regenerative Medicine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Therapy
8.2.2. By Application
8.2.3. By Material
8.2.4. By Cell
8.2.5. By Product
8.2.6. By Technique
8.2.7. By Distribution Channel
8.2.8. By Country (United States; Canada; Mexico and Rest of North America)
8.3. Europe: Country Analysis
8.3.1. France Regenerative Medicine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value & Volume
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapy
8.3.1.2.2. By Application
8.3.1.2.3. By Material
8.3.1.2.4. By Cell
8.3.1.2.5. By Product
8.3.1.2.6. By Technique
8.3.1.2.7. By Distribution Channel
8.3.2. Germany Regenerative Medicine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value & Volume
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapy
8.3.2.2.2. By Application
8.3.2.2.3. By Material
8.3.2.2.4. By Cell
8.3.2.2.5. By Product
8.3.2.2.6. By Technique
8.3.2.2.7. By Distribution Channel
8.3.3. United Kingdom Regenerative Medicine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value & Volume
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapy
8.3.3.2.2. By Application
8.3.3.2.3. By Material
8.3.3.2.4. By Cell
8.3.3.2.5. By Product
8.3.3.2.6. By Technique
8.3.3.2.7. By Distribution Channel
8.3.4. Italy Regenerative Medicine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value & Volume
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapy
8.3.4.2.2. By Application
8.3.4.2.3. By Material
8.3.4.2.4. By Cell
8.3.4.2.5. By Product
8.3.4.2.6. By Technique
8.3.4.2.7. By Distribution Channel
8.3.5. Spain Regenerative Medicine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value & Volume
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapy
8.3.5.2.2. By Application
8.3.5.2.3. By Material
8.3.5.2.4. By Cell
8.3.5.2.5. By Product
8.3.5.2.6. By Technique
8.3.5.2.7. By Distribution Channel

9. Asia-Pacific Regenerative Medicine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Therapy
9.2.2. By Application
9.2.3. By Material
9.2.4. By Cell
9.2.5. By Product
9.2.6. By Technique
9.2.7. By Distribution Channel
9.2.8. By Country (United States; Canada; Mexico and Rest of North America)
9.3. Asia-Pacific: Country Analysis
9.3.1. South Korea Regenerative Medicine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value & Volume
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapy
9.3.1.2.2. By Application
9.3.1.2.3. By Material
9.3.1.2.4. By Cell
9.3.1.2.5. By Product
9.3.1.2.6. By Technique
9.3.1.2.7. By Distribution Channel
9.3.2. China Regenerative Medicine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value & Volume
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapy
9.3.2.2.2. By Application
9.3.2.2.3. By Material
9.3.2.2.4. By Cell
9.3.2.2.5. By Product
9.3.2.2.6. By Technique
9.3.2.2.7. By Distribution Channel
9.3.3. Japan Regenerative Medicine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value & Volume
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapy
9.3.3.2.2. By Application
9.3.3.2.3. By Material
9.3.3.2.4. By Cell
9.3.3.2.5. By Product
9.3.3.2.6. By Technique
9.3.3.2.7. By Distribution Channel
9.3.4. India Regenerative Medicine Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value & Volume
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Therapy
9.3.4.2.2. By Application
9.3.4.2.3. By Material
9.3.4.2.4. By Cell
9.3.4.2.5. By Product
9.3.4.2.6. By Technique
9.3.4.2.7. By Distribution Channel
9.3.5. Australia Regenerative Medicine Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value & Volume
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Therapy
9.3.5.2.2. By Application
9.3.5.2.3. By Material
9.3.5.2.4. By Cell
9.3.5.2.5. By Product
9.3.5.2.6. By Technique
9.3.5.2.7. By Distribution Channel

10. Middle East and Africa Printing Ink Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Therapy
10.2.2. By Application
10.2.3. By Material
10.2.4. By Cell
10.2.5. By Product
10.2.6. By Technique
10.2.7. By Distribution Channel
10.2.8. By Country (United States; Canada; Mexico and Rest of North America)
10.3. MEA: Country Analysis
10.3.1. South Africa Regenerative Medicine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value & Volume
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapy
10.3.1.2.2. By Application
10.3.1.2.3. By Material
10.3.1.2.4. By Cell
10.3.1.2.5. By Product
10.3.1.2.6. By Technique
10.3.1.2.7. By Distribution Channel
10.3.2. Saudi Arabia Regenerative Medicine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value & Volume
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapy
10.3.2.2.2. By Application
10.3.2.2.3. By Material
10.3.2.2.4. By Cell
10.3.2.2.5. By Product
10.3.2.2.6. By Technique
10.3.2.2.7. By Distribution Channel
10.3.3. UAE Regenerative Medicine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value & Volume
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapy
10.3.3.2.2. By Application
10.3.3.2.3. By Material
10.3.3.2.4. By Cell
10.3.3.2.5. By Product
10.3.3.2.6. By Technique
10.3.3.2.7. By Distribution Channel

11. South America Regenerative Medicine Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Therapy
11.2.2. By Application
11.2.3. By Material
11.2.4. By Cell
11.2.5. By Product
11.2.6. By Technique
11.2.7. By Distribution Channel
11.2.8. By Country (United States; Canada; Mexico and Rest of North America)
11.3. South America: Country Analysis
11.3.1. Brazil Regenerative Medicine Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value & Volume
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Therapy
11.3.1.2.2. By Application
11.3.1.2.3. By Material
11.3.1.2.4. By Cell
11.3.1.2.5. By Product
11.3.1.2.6. By Technique
11.3.1.2.7. By Distribution Channel
11.3.2. Argentina Regenerative Medicine Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value & Volume
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Therapy
11.3.2.2.2. By Application
11.3.2.2.3. By Material
11.3.2.2.4. By Cell
11.3.2.2.5. By Product
11.3.2.2.6. By Technique
11.3.2.2.7. By Distribution Channel
11.3.3. Colombia Regenerative Medicine Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value & Volume
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Therapy
11.3.3.2.2. By Application
11.3.3.2.3. By Material
11.3.3.2.4. By Cell
11.3.3.2.5. By Product
11.3.3.2.6. By Technique
11.3.3.2.7. By Distribution Channel

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Novartis AG
14.2.2. Vericel
14.2.3. Integra Lifesciences
14.2.4. Mimedx Group
14.2.5. Stryker
14.2.6. Wright Medical
14.2.7. Roche
14.2.8. Bristol-Myers Squibb
14.2.9. Allergan
14.2.10. Corline Biomedical
14.2.11. Cook Biotech
14.2.12. Pfizer
14.2.13. Baxter
14.2.14. Boehringer Ingelheim
14.2.15. Caladrius Biosciences
14.2.16. Takara Bio
14.2.17. Medtronic
14.2.18. Osiris Therapeutics
14.2.19. Kite Pharma
14.2.20. Organogenesis

15. Strategic Recommendations

16. About Us and Disclaimer
Note: Product cover images may vary from those shown
  • Novartis AG
  • Vericel
  • Integra Lifesciences
  • Mimedx Group
  • Stryker
  • Wright Medical
  • Roche
  • Bristol-Myers Squibb
  • Allergan
  • Corline Biomedical
  • Cook Biotech
  • Pfizer
  • Baxter
  • Boehringer Ingelheim
  • Caladrius Biosciences
  • Takara Bio
  • Medtronic
  • Osiris Therapeutics
  • Kite Pharma
  • Organogenesis
Note: Product cover images may vary from those shown
Adroll
adroll